tiprankstipranks
Advertisement
Advertisement

RLMD Stock Latest News

Relmada Therapeutics Increases Authorized Shares After Shareholder Vote
Company AnnouncementsRelmada Therapeutics Increases Authorized Shares After Shareholder Vote
6d ago
8K
RLMD
Relmada Therapeutics Charts Ambitious NDV-01 Phase 3 Path
PremiumCompany Announcements
Relmada Therapeutics Charts Ambitious NDV-01 Phase 3 Path
21d ago
RLMD
Relmada Therapeutics files automatic mixed securities shelf
PremiumThe Fly
Relmada Therapeutics files automatic mixed securities shelf
21d ago
RLMD
Relmada Highlights NDV-01 Phase 2 Data, Phase 3 Plans
PremiumCompany Announcements
Relmada Highlights NDV-01 Phase 2 Data, Phase 3 Plans
22d ago
8K
RLMD
Relmada Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Relmada Therapeutics initiated with an Overweight at Piper Sandler
2M ago
RLMD
Relmada Therapeutics Charts Aggressive Path After Earnings Call
PremiumCompany AnnouncementsRelmada Therapeutics Charts Aggressive Path After Earnings Call
2M ago
RLMD
Relmada Highlights NDV-01 Data, Funding in 2025 Results
Premium
Company Announcements
Relmada Highlights NDV-01 Data, Funding in 2025 Results
2M ago
8K
RLMD
Relmada Therapeutics price target raised to $19 from $10 at Mizuho
Premium
The Fly
Relmada Therapeutics price target raised to $19 from $10 at Mizuho
3M ago
RLMD
Relmada’s Withdrawn Phase 3 Bladder Cancer Trial: What It Means for RLMD Investors
PremiumCompany Announcements
Relmada’s Withdrawn Phase 3 Bladder Cancer Trial: What It Means for RLMD Investors
3M ago
RLMD
Relmada’s Withdrawn BOOST Trial Resets Expectations for NDV-01 and RLMD
PremiumCompany Announcements
Relmada’s Withdrawn BOOST Trial Resets Expectations for NDV-01 and RLMD
3M ago
RLMD
Relmada Therapeutics Inc (RLMD) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Relmada Therapeutics Inc (RLMD) Q4 Earnings Cheat Sheet
3M ago
RLMD
Morning News Wrap-Up 3/9/26: Monday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up 3/9/26: Monday’s Biggest Stock Market Stories!
3M ago
GE
MU
Midday Fly By: Hims & Hers reaches Novo deal, Live Nation settles with DOJ
PremiumThe FlyMidday Fly By: Hims & Hers reaches Novo deal, Live Nation settles with DOJ
3M ago
MU
VZ
Why Is Relmada Therapeutics Stock (RLMD) Up Today?
Premium
Market News
Why Is Relmada Therapeutics Stock (RLMD) Up Today?
3M ago
RLMD
Relmada Therapeutics prices 29.47M shares at $4.75 in private placement
Premium
The Fly
Relmada Therapeutics prices 29.47M shares at $4.75 in private placement
3M ago
RLMD
Relmada Therapeutics Raises Capital, Highlights Promising NDV-01 Data
PremiumCompany Announcements
Relmada Therapeutics Raises Capital, Highlights Promising NDV-01 Data
3M ago
8K
RLMD
Relmada Therapeutics reports 12-month Phase 2 interim data for NDV-01
PremiumThe Fly
Relmada Therapeutics reports 12-month Phase 2 interim data for NDV-01
3M ago
RLMD
Relmada Therapeutics initiated with a Buy at Lucid Capital
PremiumThe Fly
Relmada Therapeutics initiated with a Buy at Lucid Capital
3M ago
RLMD
Relmada Therapeutics assumed at Outperform from Market Perform at Leerink
PremiumThe Fly
Relmada Therapeutics assumed at Outperform from Market Perform at Leerink
4M ago
RLMD
Relmada’s New Phase 3 Bladder Cancer Trial Adds a Fresh Catalyst to Its Pipeline
PremiumCompany AnnouncementsRelmada’s New Phase 3 Bladder Cancer Trial Adds a Fresh Catalyst to Its Pipeline
5M ago
RLMD
Relmada Therapeutics provides regulatory update on FDA alignment for NDV-01
Premium
The Fly
Relmada Therapeutics provides regulatory update on FDA alignment for NDV-01
5M ago
RLMD
Relmada’s BOOST Phase 3 Bladder Cancer Trial Sets Up a New Catalyst for RLMD Investors
Premium
Company Announcements
Relmada’s BOOST Phase 3 Bladder Cancer Trial Sets Up a New Catalyst for RLMD Investors
5M ago
RLMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >